Antibodies to Folate Receptors Impair Embryogenesis and Fetal Development in the Rat

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 10, 2003, Pages 837-847

  Da Costa, Maria ^a   Sequeira, Jeffrey M ^a   Rothenberg, Sheldon P ^a   Weedon, Jeremy ^b  

^a SUNY Downstate Medical Center   (United States)

^b Scientific Computing Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DEXAMETHASONE; FOLATE RECEPTOR; FOLIC ACID; FOLINIC ACID; UNCLASSIFIED DRUG; VITAMIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DIET SUPPLEMENTATION; DOSE RESPONSE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO RESORPTION; EPITHELIUM CELL; FEMALE; FETUS; FETUS DEVELOPMENT; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MALE; NEURAL TUBE DEFECT; NONHUMAN; OOCYTE; ORGANOGENESIS; OVIDUCT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; TERATOGENICITY;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CARRIER PROTEINS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG THERAPY, COMBINATION; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FOLIC ACID; INJECTIONS, INTRAPERITONEAL; LEUCOVORIN; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE;

EID: 0242381331     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10088     Document Type: Article

References (75)

1. Antony AC, Hansen DK. 2000. Hypothesis: folate responsive neural tube defects and folate neurocristopathies. Teratology 62:42-50.
2. Arnold J, Holmes Z, Pickering W, et al. 2001. Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 113:911-914.
3. Barber RC, Shaw GM, Lammer EJ, et al. 1998. Lack of association between mutations in the folate receptor-alpha gene and spina bifida. Am J Med Genet 76:310-317.
4. Barber RC, Lammer EJ, Shaw GM, et al. 1999. Minireview. The role of folate transport and metabolism in neural tube defect risk. Mol Genet Metab 66:1-9.
5. Barrow MV, Taylor WJ. 1971a. The production of congenital heart defects with the use of antisera to rat kidney, placenta, heart, and lung homogenates. Am Heart J 82:199-206.
6. Barrow M, Taylor WJ. 1971b. The production of congenital defects in rats using antisera. J Exp Zool 176:41-59.
7. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention [corrected; erratum to be published]. N Engl J Med 341:1485-1490. [corrected erratum, 341:1864)
8. Birn H, Selhub J, Christensen EI. 1993. Internalization and intracellular transport of folate-binding protein in rat kidney proximal tubule. Am J Physiol 264:C302-C310.
9. Botto LD, Mastroiacovo P. 1998. Exploring gene-gene interactions in the etiology of neural tube defects. Clin Genet 53:456-459.
10. Brent RL, Averich E, Drapiewski VA. 1961. Production of congenital malformations using tissue antisera I. Kidney antisera. Proc Soc Exp Biol Med 106:523-526.
11. Brent RL. 1967. Production of congenital malformations using tissue antisera. III. Placental antiserum. Proc Soc Exp Biol Med 125:1024-1029.
12. Burgoon JM, Selhub J, Nadeau M, Sadler TW. 2002. Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model. Teratology 65:219-227.
13. Christensen B, Arbour L, Tran P, et al. 1999. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84:151-157.
14. Clark DA, Coulam CB, Daya S, Chaouat G. 2001. Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum Reprod Update 7:501-511.
15. Coulam CB. 2000. Understanding the immunobiology of pregnancy and applying it to treatment of recurrent pregnancy loss. Early Pregnancy 4:19-29.
16. Cowchock S. 1997. Autoantibodies and pregnancy loss. N Engl J Med 337:197-198.
17. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
18. da Costa M, Rothenberg SP. 1996. Purification and characterization of folate binding proteins from rat placenta. Biochim Biophys Acta 1292:23-30.
19. da Costa M, Rothenberg SP, Sadasivan E, et al. 2000. Folate deficiency reduces the GPI-anchored folate-binding protein in rat renal tubules. Am J Physiol Cell Physiol 278:C812-C821.
20. de Franchis R, Sebastio G, Mandata C, et al. 1995. Spina bifida 677C-T mutation and role of folate [letter]. Lancet 346:1703.
21. de Marco P, Moroni A, Merello E, et al. 2000. Folate pathway gene alterations in patients with neural tube defects. Am J Med Genet 95:216-223.
22. Finnell RH, Wlodarczyk B, Spiegelstein O, et al. 2002. Folate transport abnormalities and congenital defects. In: Milstein S, Kapatos G, Levine RA, Shane B, editors. Chemistry and biology of pteridines and folates. Norwich, MA: Kluwer Academic Publishers. p 637-642.
23. Giles C. 1966. An account of 335 cases of megaloblastic anemia of pregnancy and peurperium. J Clin Pathol 19:1-11.
24. Heid MK, Bills ND, Hinrichs SH, Clifford AJ. 1992. Folate deficiency alone does not produce neural tube defects in mice. J Nutr 122:888-894.
25. Henderson GB, Suresh MR, Vitols KS, Huennekens FM. 1986. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate. Cancer Res 46:1639-1643.
26. Henderson GI, Perez T, Schenker S, et al. 1995. Maternal-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery. J Lab Clin Med 126:184-203.
27. Hibbard BM. 1964. The role of folic acid in pregnancy with particular reference to anemia, abruption and abortion. J Obstet Gyn 72:529-542.
28. Hibbard ED, Smithells RW. 1965. Folic acid metabolism-human embryopathy. Lancet 1:1254-1256.
29. Hogan AG, O'Dell B, Whitley JR. 1950. Maternal nutrition and hydrocephalus in newborn rats. Proc Soc Exp Biol Med 74:293-296.
30. Kamen BA, Wang MT, Streckfuss AJ, et al. 1988. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602-13609.
31. Kirke PN, Molloy AM, Daly LE, et al. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86:703-708.
32. Koch MC, Stegmann K, Ziegler A, et al. 1998. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157:487-492.
33. Laurence KM, James N, Miller MH, et al. 1981. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 282:1509-1511.
34. Laurence KM, Campbell H, James N. 1983. The role of improvement in maternal diet and periconceptual folic acid supplementation in the prevention of neural tube defects. In: Dobbing J, editor. Prevention of spina bifida and other neural tube defects. London: Academic Press. p 85-106.
35. Lucock M. 2000. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71:121-138.
36. Luhrs CA, Slomiany BL. 1989. A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail. J Biol Chem 264:21446-21449.
37. Miller PN, Pratten MK, Beck F. 1989. Growth of 9.5-day rat embryos in folic-acid-deficient serum. Teratology 39:375-385.
38. Moyers S, Bailey LB. 2001. Fetal malformations and folate metabolism: review of recent evidence. Nutr Rev 59:215-224.
39. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of a Medical Research Council vitamin study. Lancet 348:1037-1038.
40. Naparstek Y, Plotz PH. 1993. The role of autoantibodies in autoimmune disease. Annu Rev Immunol 11:79-104.
41. Nelson MM, Evans HM. 1947. Reproduction in the rat on purified diets containing succinylsulfathiazine. Proc Soc Exp Biol Med 66:289-391.
42. Nelson MM, Evans HM. 1949. Pteroylglutamic acid and reproduction in the rat. J Nutr 3838:11-24.
43. Nelson MM, Asing CW, Evans HM. 1952. Production of multiple congenital abnormalities in young by maternal pteroylglutamic acid deficiency during gestation. J Nutr 48:61-80.
44. Nelson MM, Wright HV, Asling C, Evans HM. 1955. Multiple congenital abnormalities resulting from transitory deficiency of pteroylglutamic acid during gestation in the rat. J Nutr 56:349-370.
45. Nelson MM, Wright HV, Baird CDC, Evans HM. 1956. Effect of 36-hr period of pteroylglutamic acid deficiency on fetal development in the rat. Proc Soc Exp Biol Med 92:554-556.
46. Nelson MM. 1960. Teratogenic effects of pteroylglutamic acid deficiency in the rat. In: Wolstenholme GEW, O'Connor CM, editors. CIBA Foundation Symposium on Congenital Malformations. Boston: Little, Brown and Company. p 134-157.
47. O'Dell JR, Whitley JR, Hogan AG. 1948. Relation of folic acid and vitamin A to incidence of hydrocephalus in infant rats. Proc Soc Exp Biol Med 69:272-275.
48. Page ST, Owen WC, Price K, Elwood PC. 1993. Expression of the human folate receptor transcript is regulated in human tissues. J Mol Biol 229:1175-1183.
49. Piedrahita JA, Oetama B, Bennett GD, et al. 1999. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23:228-232.
50. Posey DL, Khoury MJ, Mulinare J, et al. 1996. Is mutated MTHFR a risk factor for neural tube defects? Lancet 347:686-687.
51. Raynaud F, Horvath C. 1994. Folate deficiency and congenital malformations induced by pyrimethamine in the rat. Reprod Nutr Dev 34:461-471.
52. Richardson LR, Hogan AG. 1946. Diet of mother and hydrocephalus in infant rats. J Nutr 32:459.
53. Rosenquist TH, Finnell RH. 2001. Genes, folate and homocysteine in embryonic development. Proc Nutr Soc 60:53-61.
54. 5-formytetrahydrofolic acid (citrovorum factor) in serum and urine. Anal Biochem 93:483-487.
55. Sadasivan E, da Costa M, Rothenberg SP, Brink L. 1987. Purification, properties, and immunological characterization of folate-binding proteins from human leukemia cells. Biochim Biophys Acta 925:36-47.
56. Schorah CJ, Wild J, Hartley R, et al. 1983. The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br J Nutr 49:203-211.
57. Scott JM, Weir DG, Molloy A, et al. 1994. Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp 181:180-187.
58. Shaw GM, Schaffer D, Velie EM, et al. 1995. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-226.
59. Shen F, Ross JF, Wang X, Ratnam M. 1994. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 33:1209-1215.
60. Shields DC, Kirke PN, Mills JL, et al. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055.
61. Slotnick V, Brent RL. 1966. The production of congenital malformations using tissue antisera. V. Fluorescent localization of teratogenic antisera in the maternal and fetal tissue of the rat. J Immunol 96:606-610.
62. Smithells RW, Sheppard S, Schorah CJ. 1976. Vitamin deficiencies and neural tube defects. Arch Dis Child 51:944-950.
63. Smithells RW, Sheppard S. 1980. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1:647.
64. Smithells RW, Sheppard S, Schorah CJ, et al. 1981a. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 56:911-918.
65. Smithells RW, Sheppard S, Schorah CJ, et al. 1981b. Vitamin supplementation and neural tube defects. Lancet 2:1425.
66. Smithells RW, Nevin NC, Seller MJ, et al. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1:1027-1031.
67. Tagbo IF, Hill DC. 1976. Effect of folic acid deficiency on pregnant rats and their offspring. Can J Physiol Pharmacol 55:427-433.
68. Trembath D, Sherbondy AL, Vandyke DC, et al. 1999. Analysis of select folate pathway genes, PAX3, and human NTD in a midwestern neural tube defect population. Teratology 59:331-341.
69. Ubbink JB, Christianson A, Bester MJ, et al. 1999. Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects. Metabolism 48:269-274.
70. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
71. van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, et al. 1996. Decreased methylene tetrahydrofolate reductase activity due to the 677C-T mutation in families with spina bifida offspring. J Mol Med 74:691-694.
72. van der Put NM, Eskes TK, Blom HJ. 1997. Is the common 677C-T mutation in the methylene tetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Q J Med 90:111-115.
73. van der Put NM, Gabreels F, Stevens EM, et al. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051.
74. Werler MM, Shapiro S, Mitchell AA. 1993. Periconceptional folic acid exposure and risk of neural tube defects. J Am Med Assoc 269:1257-1261.
75. Zhao R, Russell RG, Wang Y, et al. 2001. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem 276:10224-10228.